Researchers at Fred Hutchinson Cancer Center have developed a new hybridoma cell line that expresses mouse Thy1.1 (CD90.1) antibodies.
Reference:
- Bernstein, et al. 1980 (DOI: 10.1126/science.6965328)
Available Licenses
To license this product, please complete, sign and return the license agreement to bds@fredhutch.org. Further instructions are provided therein.
Please Note: Academic and non-profit users may license the material for free. Fees for for-profit users are listed in the license agreements. All recipients must pay a fee for material preparation and shipping expenses.
Download license agreement
Commerical Use | Non-commerical Use
Credit Line for Acknowledgement
When publishing on the use of this material, please provide credit to Dr. Irwin Bernstein according to accepted publications standards.
Questions About this Product?
